These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 32739275
1. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis. Rahman SU, Ali HS, Jafari B, Zaib S, Hameed A, Al-Kahraman YMSA, Langer P, Iqbal J. Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275 [Abstract] [Full Text] [Related]
2. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Diabetes mellitus Predicted by 3D QSAR Pharmacophore Models, Molecular Docking and de novo Evolution. Musoev A, Numonov S, You Z, Gao H. Molecules; 2019 Aug 07; 24(16):. PubMed ID: 31394858 [Abstract] [Full Text] [Related]
3. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors. Patel BD, Bhadada SV, Ghate MD. Bioorg Chem; 2017 Jun 07; 72():345-358. PubMed ID: 28302310 [Abstract] [Full Text] [Related]
4. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation. Meduru H, Wang YT, Tsai JJ, Chen YC. Int J Mol Sci; 2016 Jun 13; 17(6):. PubMed ID: 27304951 [Abstract] [Full Text] [Related]
5. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation. Xing J, Li Q, Zhang S, Liu H, Zhao L, Cheng H, Zhang Y, Zhou J, Zhang H. Chem Biol Drug Des; 2014 Sep 13; 84(3):364-77. PubMed ID: 24674599 [Abstract] [Full Text] [Related]
6. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Li N, Wang LJ, Jiang B, Li XQ, Guo CL, Guo SJ, Shi DY. Eur J Med Chem; 2018 May 10; 151():145-157. PubMed ID: 29609120 [Abstract] [Full Text] [Related]
7. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated in silico approaches. Sharma S, Srivastava S, Shrivastava A, Malik R, Almalki F, Saifullah K, Alam MM, Shaqiquzzaman M, Ali S, Akhter M. J Biomol Struct Dyn; 2020 Nov 10; 38(18):5349-5361. PubMed ID: 31813365 [Abstract] [Full Text] [Related]
8. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among Moringa oleifera Phytochemicals by Virtual Screening, Molecular Docking Analysis, ADME/T-Based Prediction, and In Vitro Analyses. Yang Y, Shi CY, Xie J, Dai JH, He SL, Tian Y. Molecules; 2020 Jan 02; 25(1):. PubMed ID: 31906524 [Abstract] [Full Text] [Related]
9. Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents. Agrawal R, Jain P, Dikshit SN. Comb Chem High Throughput Screen; 2012 Dec 02; 15(10):849-76. PubMed ID: 23140189 [Abstract] [Full Text] [Related]
10. New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study. Almasri IM, Taha MO, Mohammad MK. Arch Pharm Res; 2013 Nov 02; 36(11):1326-37. PubMed ID: 23918649 [Abstract] [Full Text] [Related]
11. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis. Khalaf RA, Masalha D, Sabbah D. Curr Comput Aided Drug Des; 2020 Nov 02; 16(3):295-307. PubMed ID: 30526469 [Abstract] [Full Text] [Related]
12. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4. Mishra A, Cross M, Hofmann A, Coster MJ, Karim A, Sattar A. J Comput Biol; 2019 Dec 02; 26(12):1470-1486. PubMed ID: 31390221 [Abstract] [Full Text] [Related]
17. In silico Studies on the Interaction Between Bioactive Ligands and DPPIV: Insights on Potential Candidates for the Treatment of type 2 Diabetes Mellitus. Martins MCMR, Pantaleao SQ, de Oliveira Almeida M, Weber KC, Honorio KM. Med Chem; 2021 Dec 02; 17(3):247-263. PubMed ID: 31995015 [Abstract] [Full Text] [Related]
19. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554. Maezaki H, Banno Y, Miyamoto Y, Moritoh Y, Asakawa T, Kataoka O, Takeuchi K, Suzuki N, Ikedo K, Kosaka T, Sasaki M, Tsubotani S, Tani A, Funami M, Yamamoto Y, Tawada M, Aertgeerts K, Yano J, Oi S. Bioorg Med Chem; 2011 Aug 01; 19(15):4482-98. PubMed ID: 21741847 [Abstract] [Full Text] [Related]
20. An Update on Dipeptidyl Peptidase-IV Inhibiting Peptides. Sivaraman SA, Sabareesh V. Curr Protein Pept Sci; 2024 Aug 01; 25(4):267-285. PubMed ID: 38173201 [Abstract] [Full Text] [Related] Page: [Next] [New Search]